ORBIMED CAPITAL LLC - Q4 2002 holdings

Add to watchlist

$233 Billion is the total value of ORBIMED CAPITAL LLC's 29 reported holdings in Q4 2002. The portfolio turnover from Q3 2002 to Q4 2002 was - .

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
No holdings reported for quarter Q4 2002
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2003-02-14
Latest significant ownerships (13-D/G)
ORBIMED CAPITAL LLC Q4 2002 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
CYBIN INC.February 14, 20236,153,2993.7%
Milestone Pharmaceuticals Inc.Sold outFebruary 14, 202300.0%
Aptose Biosciences Inc.Sold outFebruary 11, 202200.0%
SI-BONE, Inc.February 11, 20222,305,3006.9%
Foamix Pharmaceuticals Ltd.February 14, 20202,577,9824.2%
CRYOCOR INCJune 19, 2007389,4323.2%
DOV PHARMACEUTICAL INCSold outAugust 15, 200600.0%
GIVEN IMAGING LTDAugust 14, 20063,637,25513.3%
ORPHAN MEDICAL INCMay 06, 20051,080,0009.4%
TANOX INCOctober 14, 20043,851,3008.8%

View ORBIMED CAPITAL LLC's complete significant-ownership history.

Latest filings
TypeFiled
42024-04-05
13F-NT2024-02-14
1442023-12-11
13F-NT2023-11-14
1442023-10-02
42023-08-31
1442023-08-30
1442023-08-21
1442023-08-15
13F-NT2023-08-14

View ORBIMED CAPITAL LLC's complete filings history.

All filings

View complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (233005569000.0 != 0.0)
  • The reported number of holdings is incorrect (29 != 0)

Export ORBIMED CAPITAL LLC's holdings

CSVXLS